Two acquisitions have been agreed to or completed in the orthopedic device industry in the past month:
Smith+Nephew agreed to acquire the extremity orthopedics business from Integra LifeSciences for $240 million in cash. The deal is set to be completed by the end of the year.
Orthobiologics company Royal Biologics acquired the Fibrinet system from Vertical Spine, strengthening its portfolio of autologous and live cellular solutions for spinal fusion.